Cached score snapshot

US.COO · Cooper Companies (The)

110分制 46.6/110;5D動能v2 7/50;排序分 53.6/160

Ranking score 53.6/160
Main score 46.6/110
5D momentum v2 7/50
Rank #340
Setup grade F 23.7

Score breakdown

避免

Medium twelvedata

Score and price trend

F 23.7 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-12 07-17 08-19 09-22 10-20 $60.71$71.79$82.87 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.226 · anchors 120 +1.19% -0.82% / +3.63% 58.8% 0% Actual outcome pending · 1 / 3 bars observed
30D observation +8.93% -0.26% / +15.98% 73.8% 10% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.58% -0.85% / +4.64% 63.8% 1.9% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-12 → 2026-10-20 · 90 archived points · 2 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 53.6
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 46.6/110 (避免)
5D momentum v2 7/50 (弱)
Score with momentum v2 53.6/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 73.348
ma50 72.5786
close 67.69
prevClose 69.59
avgVolume20 1674394
volumeRatio 1.75
changePercent -2.73

Metrics snapshot

close 67.69
volume 2924886
changePercent -2.73

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 46.6/110
Main rating 避免
5D momentum v2 7/50
Score with momentum v2 53.6/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.1/5 · 較差

Dimension score 2.1/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 197.9855
volumePoints 0.5
revenuePoints 0
dividendPoints 0
marketCapPoints 0.4

資金流 — 8.4/20 · 較差

Dimension score 8.4/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 0.8
obvPoints 4
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.COO
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 9.6/15 · 一般

Dimension score 9.6/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.3

trend

score 3.4

details

qqq

ma20 717.385
ma50 711.3218
name QQQ
close 718.36
points 2

spy

ma20 768.6995
ma50 757.5966
name SPY
close 765.96
points 1.4
source twelvedata+fred
atrPct 2.2751
atrPoints 3
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10
Dimension grade 良好

Sub-items

position

score 1.4

details

atrPct 2.2751
turnoverUsdM 197.9855
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.COO
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 64.61

strength_details

ma_score 2
atr_score 2
rsi_score 2.5
macd_score 1
volume_score 2
market_adjustment 1
risk_reward_ratio 1.2
stop_loss_percent 4.6
take_profit_price 71.2987
target_multiplier 1.9
technical_strength 1.85
take_profit_percent 5.3
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 4.5502
diversificationPoints 2

技術信號 — 13.3/30 · 較差

Dimension score 13.3/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 0.6
macdPoints 0.8

vcpPayload

vcp_pass false
vcp_score 0.6
vcp_reason 跌縮量(近10日4日);Ready=N;Confirm=N

vcp_metrics

up_days 3
vol_ref 1745630
down_days 6
vcp_ready false
above_ma50 false
avg_vol_10 1581910
avg_vol_20 1647450
avg_vol_30 1745630
range_pct_10 0.1108
range_pct_20 0.1334
range_pct_30 0.1334
up_expand_ok false
lookback_used 59
near_20d_high false
contraction_ok false
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.9062
dist_to_20d_high 0.1334
down_shrink_days 4
breakout_level_20d 78.11
vcp_breakout_confirm false
contraction_ratio_10_30 0.8306
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 0.8
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 1
positiveHits 3
sentimentScoreRaw 0.6

sentimentData

raw {"id":141951311,"url":"https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.","category":"company","datetime":1788837891,"headline":"CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"}, {"id":141399367,"url":"https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.","category":"company","datetime":1788441302,"headline":"Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"}, {"id":141285387,"url":"https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"COO vs. MMSI: Which Stock Is the Better Value Option?","category":"company","datetime":1787330403,"headline":"COO vs. MMSI: Which Stock Is the Better Value Option?"}, {"id":141285388,"url":"https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...","category":"company","datetime":1787285899,"headline":"Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"}, {"id":141285389,"url":"https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...","category":"company","datetime":1787275122,"headline":"Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"}, {"id":141285398,"url":"https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...","category":"company","datetime":1787256559,"headline":"Cooper Companies (COO) Stock Trades At A Premium To Fair Value"}, {"id":141285390,"url":"https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.","category":"company","datetime":1787156762,"headline":"CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"}, {"id":141285391,"url":"https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.","category":"company","datetime":1787074740,"headline":"COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"}
raw_source {"id":141951311,"url":"https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.","category":"company","datetime":1788837891,"headline":"CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"}, {"id":141438250,"url":"https://finnhub.io/api/news?id=b32b18f70a2d6d97d3dfacec4155e52722a9bfb88b7fdbe7045235e8b9b7f072","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.","category":"company","datetime":1788533460,"headline":"Reasons to Hold HealthEquity Stock in Your Portfolio for Now"}, {"id":141438251,"url":"https://finnhub.io/api/news?id=5312f8fd75a4bee8e63dde36cadd4968060945ef5f913769b304adbf66335ba5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.","category":"company","datetime":1788533100,"headline":"Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC"}, {"id":141402952,"url":"https://finnhub.io/api/news?id=3d3feccc82059226879876f1951569b64ecda9577a6127905cd7eefbeb5eb152","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.","category":"company","datetime":1788457140,"headline":"Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"}, {"id":141402704,"url":"https://finnhub.io/api/news?id=b3b1ef4df8c77bd564b8c103e476159f06b03899b3c6c49a40a0d45a15c635c7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.","category":"company","datetime":1788457020,"headline":"Stryker Launches FDA-Cleared Apple Vision Pro Surgical App"}, {"id":141399367,"url":"https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.","category":"company","datetime":1788441302,"headline":"Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"}, {"id":141380178,"url":"https://finnhub.io/api/news?id=2b8d1aacd8f484827e4d64710c3d4f8e5e1c531af9bc90fd4134f334d7300c3e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.","category":"company","datetime":1788373980,"headline":"Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition"}, {"id":141369419,"url":"https://finnhub.io/api/news?id=4bd86a988eee4c33fde06d22a28a6737f81f8890d6785a55ea35331324c27c98","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1820742209/image_1820742209.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"COO","summary":"Cooper Companies (COO) outlook: premium lens growth, margin gains, stronger cash flow & possible CooperSurgical sale. Click here to read my latest analysis.","category":"company","datetime":1788271357,"headline":"Cooper Companies: Cash Conversion And Strategic Optionality Create A Re-Rating Setup"}, {"id":141365559,"url":"https://finnhub.io/api/news?id=d58555be66b9153b3509317d8f0bfffb9ece0b3b3d239d0aee4d7fadfd2d4453","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Ostrom Climate Solutions Inc. (\"Ostrom\" or the \"Company\") (TSXV: COO) (Frankfurt: 9EAA), a leading provider of carbon project development, net-zero climate solutions, and carbon credit marketing and trading, today announced its unaudited financial results for the second quarter ended June 30, 2026.","category":"company","datetime":1787967300,"headline":"OSTROM CLIMATE REPORTS FISCAL Q2 2026 FINANCIAL STATEMENTS"}, {"id":141364000,"url":"https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.","category":"company","datetime":1787935140,"headline":"CVRx Secures Devoted Health Coverage for Barostim Therapy"}, {"id":141365561,"url":"https://finnhub.io/api/news?id=6a40905df7f445dc78f726199748517e4546d4a7186f78375096b3faa160f6ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.","category":"company","datetime":1787923972,"headline":"1 Mid-Cap Stock with Impressive Fundamentals and 2 Facing Challenges"}, {"id":141364236,"url":"https://finnhub.io/api/news?id=5e22d4a74cec5831ef1bd013a9cb7f136d6596bc1e6054a8fc66b2fcd85827ce","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"VEEV's Q2 fiscal 2027 earnings and revenues top estimates, while strong Vault CRM momentum and a raised full-year outlook drive shares higher.","category":"company","datetime":1787848260,"headline":"Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up"}, {"id":141317763,"url":"https://finnhub.io/api/news?id=d9a2b22a4880b4c57a5a78e197c6c5ce8a510e121a48982bd29dab32dc155385","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"COO","summary":"Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.","category":"company","datetime":1787684701,"headline":"Top S&P500 movers in Tuesday's session"}, {"id":141314075,"url":"https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"COO","summary":"Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.","category":"company","datetime":1787613074,"headline":"The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"}, {"id":141364562,"url":"https://finnhub.io/api/news?id=2e2a954efd2b15fc6a53a148619420c96b95f9f5a88d883a2f3870eb742f848e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.","category":"company","datetime":1787592420,"headline":"Here's Why You Should Add GEHC Stock to Your Portfolio for Now"}, {"id":141365557,"url":"https://finnhub.io/api/news?id=b60761c0d6bf3be1dac107ed638f629e5721c81459d1282b53c6579bbdfd700c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies has underperformed the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.","category":"company","datetime":1787581657,"headline":"Are Wall Street Analysts Bullish on Cooper Companies Stock?"}, {"id":141365558,"url":"https://finnhub.io/api/news?id=aadfdde577c30bc7effe7096f2d78b4eb7a56e79c4198dfbdc5ab8560dac9910","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.","category":"company","datetime":1787580816,"headline":"1 Healthcare Stock to Target This Week and 2 Facing Headwinds"}, {"id":141283982,"url":"https://finnhub.io/api/news?id=c4b2da463c6f09a31ce8e17d294cbf1644931a45b43de4a4e12c8f1e77ee8f38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.","category":"company","datetime":1787330760,"headline":"Here's Why You Should Retain Inogen Stock in Your Portfolio for Now"}, {"id":141278125,"url":"https://finnhub.io/api/news?id=c4219d4c8cc06018c3099f6575c54f4f5c3fca8777f4943262f105bf447c2dec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"JNJ's MONARCH QUEST 3 wins FDA 510(k) clearance, adding AI-powered planning, navigation and imaging upgrades for robotic bronchoscopy.","category":"company","datetime":1787330580,"headline":"Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update"}, {"id":141285387,"url":"https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"COO vs. MMSI: Which Stock Is the Better Value Option?","category":"company","datetime":1787330403,"headline":"COO vs. MMSI: Which Stock Is the Better Value Option?"}, {"id":141283984,"url":"https://finnhub.io/api/news?id=b75563b5894b58e0887a3679e9fdda1971893a4221c73767729b846b337b105a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.","category":"company","datetime":1787330040,"headline":"INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?"}, {"id":141283985,"url":"https://finnhub.io/api/news?id=b73e213a06b8ca1cf8c2e1fb47c041c4ea799d097e88e7a558e805c84d3ec268","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.","category":"company","datetime":1787329800,"headline":"BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?"}, {"id":141279656,"url":"https://finnhub.io/api/news?id=5f941718a2b3dcd6c642c392d28f14263bd1e17229ca84c001ef41096bad7251","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.","category":"company","datetime":1787328720,"headline":"Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"}, {"id":141285388,"url":"https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...","category":"company","datetime":1787285899,"headline":"Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"}, {"id":141285389,"url":"https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...","category":"company","datetime":1787275122,"headline":"Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"}, {"id":141285398,"url":"https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...","category":"company","datetime":1787256559,"headline":"Cooper Companies (COO) Stock Trades At A Premium To Fair Value"}, {"id":141281778,"url":"https://finnhub.io/api/news?id=e7adcedb141ab46bd93163e2536b035f1d90bc75f1cf4cfe9ac78f80f75695ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"BD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for incisional hernia prevention.","category":"company","datetime":1787246580,"headline":"BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study"}, {"id":141266860,"url":"https://finnhub.io/api/news?id=db611a64fbf03b230be4b5b782e1bab7a0378c9f276b9bc20f8b0c7c17ff967e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.","category":"company","datetime":1787246040,"headline":"MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor"}, {"id":141283992,"url":"https://finnhub.io/api/news?id=37eb4fb3fb259704bc8889e42d9c66402dc8110e9f56566c62af937ffc38bd2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.","category":"company","datetime":1787162100,"headline":"HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?"}, {"id":141279330,"url":"https://finnhub.io/api/news?id=30e482ac66f335fd06f9335323ecea233f86b3fec37689483b7273b323f2c7d1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"ISRG is expanding in Asia Pacific with a new Penang plant to boost capacity and support rising demand for robotic-assisted surgery.","category":"company","datetime":1787161080,"headline":"Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific"}, {"id":141285390,"url":"https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.","category":"company","datetime":1787156762,"headline":"CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"}, {"id":141283994,"url":"https://finnhub.io/api/news?id=7118fcfc455dcfff25cf8dd09c68938daf08dd78c9ed045f17f2c2487c7c2d8d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Glaukos' iDose TR and Epioxa are driving rapid growth, while margin expansion and a broad pipeline strengthen its long-term prospects.","category":"company","datetime":1787152500,"headline":"Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now"}, {"id":141285391,"url":"https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.","category":"company","datetime":1787074740,"headline":"COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"}, {"id":141249262,"url":"https://finnhub.io/api/news?id=cd84f8231493ebb18fccd9f4632072f388ae813ad5bb247d4545f99f0bf939a5","image":"https://cdn.benzinga.com/files/images/story/2026/08/18/Everpure-logo-site.png?width=2048&height=1536","source":"Benzinga","related":"COO","summary":"Jana Partners adds Everpure stock, a growing player in AI and data center market, to its portfolio. It also lowers its stake in other companies.","category":"company","datetime":1787059139,"headline":"Jana Partners Buys Stake in Data Center Stock Everpure, May Be Up Almost 100% Already"}, {"id":141250275,"url":"https://finnhub.io/api/news?id=72aa3033993c9773bbace7800f1af4af161f6496b542780f6d21fdea95613697","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"NTRA is using its Latitude MRD test in Kupando's Phase 1 skin cancer trial to track ctDNA and characterize response to KUP-101.","category":"company","datetime":1786985040,"headline":"Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer"}, {"id":141282326,"url":"https://finnhub.io/api/news?id=faba776873e4e4ba41ecf84efb154c62932d2516ceb5780783fee8a9aea8c157","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1786891260,"headline":"3 S&P 500 Stocks We Think Twice About"}, {"id":141212274,"url":"https://finnhub.io/api/news?id=b010713295d26ccd8ae361023b5941c321a3e7758d3f55adeb75362852ecfef6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"HeartFlow (HTFL) delivered earnings and revenue surprises of +50.00% and +12.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1786656902,"headline":"HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates"}, {"id":141212060,"url":"https://finnhub.io/api/news?id=025d57b24590603cb45cf65794b22e0e767d236458c1dda40e82ea69a03ca747","image":"","source":"Benzinga","related":"COO","summary":"Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:COO) with a Neutral and raises the price target from $76 to $80.","category":"company","datetime":1786639245,"headline":"Citigroup Maintains Neutral on Cooper Companies, Raises Price Target to $80"}, {"id":141205666,"url":"https://finnhub.io/api/news?id=6ffa1b74e3016ee2e16dcae1b326a2ce32afa731ce1bdc8b5deda915bb26d23a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cooper Companies' premium lens migration, MiSight growth and fertility recovery offer long-term upside despite Asia-Pacific, tariff and FX pressures.","category":"company","datetime":1786625460,"headline":"Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now"}, {"id":141202656,"url":"https://finnhub.io/api/news?id=1465d58e14aa3519a86a6ba0218b0d69cd6cbb5ace1244b8ffb95a68f77f700c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Staar Surgical (STAA) delivered earnings and revenue surprises of +47.62% and +3.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1786569002,"headline":"Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates"}, {"id":141202469,"url":"https://finnhub.io/api/news?id=e0277f3fb832d7629b5cfa40809a7c12d4b0dd92ab901d8e20bba9889d3940ae","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.","category":"company","datetime":1786548120,"headline":"NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up"}, {"id":141202034,"url":"https://finnhub.io/api/news?id=c70632c2f9259acf971a4ff2e21f3a79f70231e7041cbbc36844dbb90356e0cf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.","category":"company","datetime":1786465260,"headline":"CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up"}, {"id":141202043,"url":"https://finnhub.io/api/news?id=211c1e69d0f065f870c9c010a432db201c6207fc440f7474867a1efe9b423f3a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"Cardinal (CAH) delivered earnings and revenue surprises of +20.25% and -2.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1786449302,"headline":"Cardinal Health (CAH) Q4 Earnings Beat Estimates"}, {"id":141177784,"url":"https://finnhub.io/api/news?id=2b214d626c55d69f3321fcb009f6866c20e2d848f4d640c809751929b9c57eb4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"COO","summary":"INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.","category":"company","datetime":1786380840,"headline":"Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 1
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 44
discarded_article_count 36
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.1 5/110 42% 2.1
資金流 8.4 20/110 42% 8.4
市場環境 9.6 15/110 64% 9.6
催化劑 2 20/110 10% 2
風險管理 7.2 10/110 72% 7.2
技術信號 13.3 30/110 44.33% 13.3
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50
ret_5d -0.0342
max_score 50
max_total 50
raw_total 7
vcp_bonus 0
vol_ratio 1.7754
ret_points 0
vol_points 6
range_ratio 1.0893
volat_points 0
day_range_pct 0.0205
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.2751
turnoverUsdM 197.9855
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.COO
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 64.61

strength_details

ma_score 2
atr_score 2
rsi_score 2.5
macd_score 1
volume_score 2
market_adjustment 1
risk_reward_ratio 1.2
stop_loss_percent 4.6
take_profit_price 71.2987
target_multiplier 1.9
technical_strength 1.85
take_profit_percent 5.3
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 4.5502
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.1/5分
資金流分析總分: 8.4/20分
市場環境分析總分: 9.6/15分
催化劑分析: 2/20分
風險管理總分: 7.2/10分
技術信號分析總分: 13.3/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 78.57
atr
atr 1.54
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.28
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -126.22
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.322
kdj
d 10.96
j 1.61
k 7.84
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 22.3
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 2206514
recentSlope -679018.6
previousSlope -598750
rsi
value 19.59
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 73.2884
position SAR喺價上
distancePct 8.27
previousTrend 下降
ma50
value 72.5786
macd
macd -1.1602
trend 看跌
signal -0.4009
histogram -0.7593
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 73.2087
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.75
score 6
avgVolume 1674394
currentVolume 2924886
derived
ma20 73.348
ma50 72.5786
prevClose 69.59
avgVolume10 1760329
avgVolume20 1674394
changePercent -2.73
avgVolumeForScore 1674394
ma_cross
ma20 73.348
ma50 72.5786
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 73.7795
prevMa50 72.6452
spreadPct 1.06
isVolumeBreakout true
bollinger
lower 67.196
upper 79.5
position 中間
rsi_short
value 21.94
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.75

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.2750775594622548,
        "turnoverUsdM": 197.98553334000002,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.COO",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 64.61,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.6,
      "take_profit_price": 71.2987,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 5.3
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.5501551189245095,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 53.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 73.348,
    "ma50": 72.5786,
    "close": 67.69,
    "prevClose": 69.59,
    "avgVolume20": 1674394,
    "volumeRatio": 1.75,
    "changePercent": -2.73
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.034241634141340294,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.7754019848857325,
      "ret_points": 0,
      "vol_points": 6,
      "range_ratio": 1.089318189916201,
      "volat_points": 0,
      "day_range_pct": 0.020534790958782696,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 53.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 42,
        "contribution": 2.1
      },
      {
        "raw": 8.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 42,
        "contribution": 8.4
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 13.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 44.33,
        "contribution": 13.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.6,
    "details": [
      "基本面分析總分: 2.1/5分",
      "資金流分析總分: 8.4/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 13.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.1,
      "資金流": 8.4,
      "市場環境": 9.6,
      "情緒分析": 4,
      "技術信號": 13.3,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 197.98553334000002,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.COO",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.3
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 717.3850005500001,
                "ma50": 711.3217994399997,
                "name": "QQQ",
                "close": 718.35999,
                "points": 2
              },
              "spy": {
                "ma20": 768.6994929500001,
                "ma50": 757.5966012200001,
                "name": "SPY",
                "close": 765.96002,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.2750775594622548,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 1,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141951311,
                "url": "https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.",
                "category": "company",
                "datetime": 1788837891,
                "headline": "CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"
              },
              {
                "id": 141399367,
                "url": "https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.",
                "category": "company",
                "datetime": 1788441302,
                "headline": "Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"
              },
              {
                "id": 141285387,
                "url": "https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "COO vs. MMSI: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1787330403,
                "headline": "COO vs. MMSI: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141285388,
                "url": "https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...",
                "category": "company",
                "datetime": 1787285899,
                "headline": "Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"
              },
              {
                "id": 141285389,
                "url": "https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...",
                "category": "company",
                "datetime": 1787275122,
                "headline": "Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"
              },
              {
                "id": 141285398,
                "url": "https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...",
                "category": "company",
                "datetime": 1787256559,
                "headline": "Cooper Companies (COO) Stock Trades At A Premium To Fair Value"
              },
              {
                "id": 141285390,
                "url": "https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1787156762,
                "headline": "CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"
              },
              {
                "id": 141285391,
                "url": "https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.",
                "category": "company",
                "datetime": 1787074740,
                "headline": "COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"
              }
            ],
            "raw_source": [
              {
                "id": 141951311,
                "url": "https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.",
                "category": "company",
                "datetime": 1788837891,
                "headline": "CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"
              },
              {
                "id": 141438250,
                "url": "https://finnhub.io/api/news?id=b32b18f70a2d6d97d3dfacec4155e52722a9bfb88b7fdbe7045235e8b9b7f072",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.",
                "category": "company",
                "datetime": 1788533460,
                "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
              },
              {
                "id": 141438251,
                "url": "https://finnhub.io/api/news?id=5312f8fd75a4bee8e63dde36cadd4968060945ef5f913769b304adbf66335ba5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.",
                "category": "company",
                "datetime": 1788533100,
                "headline": "Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC"
              },
              {
                "id": 141402952,
                "url": "https://finnhub.io/api/news?id=3d3feccc82059226879876f1951569b64ecda9577a6127905cd7eefbeb5eb152",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.",
                "category": "company",
                "datetime": 1788457140,
                "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"
              },
              {
                "id": 141402704,
                "url": "https://finnhub.io/api/news?id=b3b1ef4df8c77bd564b8c103e476159f06b03899b3c6c49a40a0d45a15c635c7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.",
                "category": "company",
                "datetime": 1788457020,
                "headline": "Stryker Launches FDA-Cleared Apple Vision Pro Surgical App"
              },
              {
                "id": 141399367,
                "url": "https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.",
                "category": "company",
                "datetime": 1788441302,
                "headline": "Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"
              },
              {
                "id": 141380178,
                "url": "https://finnhub.io/api/news?id=2b8d1aacd8f484827e4d64710c3d4f8e5e1c531af9bc90fd4134f334d7300c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.",
                "category": "company",
                "datetime": 1788373980,
                "headline": "Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition"
              },
              {
                "id": 141369419,
                "url": "https://finnhub.io/api/news?id=4bd86a988eee4c33fde06d22a28a6737f81f8890d6785a55ea35331324c27c98",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1820742209/image_1820742209.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "COO",
                "summary": "Cooper Companies (COO) outlook: premium lens growth, margin gains, stronger cash flow & possible CooperSurgical sale. Click here to read my latest analysis.",
                "category": "company",
                "datetime": 1788271357,
                "headline": "Cooper Companies: Cash Conversion And Strategic Optionality Create A Re-Rating Setup"
              },
              {
                "id": 141365559,
                "url": "https://finnhub.io/api/news?id=d58555be66b9153b3509317d8f0bfffb9ece0b3b3d239d0aee4d7fadfd2d4453",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Ostrom Climate Solutions Inc. (\"Ostrom\" or the \"Company\") (TSXV: COO) (Frankfurt: 9EAA), a leading provider of carbon project development, net-zero climate solutions, and carbon credit marketing and trading, today announced its unaudited financial results for the second quarter ended June 30, 2026.",
                "category": "company",
                "datetime": 1787967300,
                "headline": "OSTROM CLIMATE REPORTS FISCAL Q2 2026 FINANCIAL STATEMENTS"
              },
              {
                "id": 141364000,
                "url": "https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.",
                "category": "company",
                "datetime": 1787935140,
                "headline": "CVRx Secures Devoted Health Coverage for Barostim Therapy"
              },
              {
                "id": 141365561,
                "url": "https://finnhub.io/api/news?id=6a40905df7f445dc78f726199748517e4546d4a7186f78375096b3faa160f6ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.",
                "category": "company",
                "datetime": 1787923972,
                "headline": "1 Mid-Cap Stock with Impressive Fundamentals and 2 Facing Challenges"
              },
              {
                "id": 141364236,
                "url": "https://finnhub.io/api/news?id=5e22d4a74cec5831ef1bd013a9cb7f136d6596bc1e6054a8fc66b2fcd85827ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "VEEV's Q2 fiscal 2027 earnings and revenues top estimates, while strong Vault CRM momentum and a raised full-year outlook drive shares higher.",
                "category": "company",
                "datetime": 1787848260,
                "headline": "Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up"
              },
              {
                "id": 141317763,
                "url": "https://finnhub.io/api/news?id=d9a2b22a4880b4c57a5a78e197c6c5ce8a510e121a48982bd29dab32dc155385",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "COO",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.",
                "category": "company",
                "datetime": 1787684701,
                "headline": "Top S&P500 movers in Tuesday's session"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "COO",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              },
              {
                "id": 141364562,
                "url": "https://finnhub.io/api/news?id=2e2a954efd2b15fc6a53a148619420c96b95f9f5a88d883a2f3870eb742f848e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.",
                "category": "company",
                "datetime": 1787592420,
                "headline": "Here's Why You Should Add GEHC Stock to Your Portfolio for Now"
              },
              {
                "id": 141365557,
                "url": "https://finnhub.io/api/news?id=b60761c0d6bf3be1dac107ed638f629e5721c81459d1282b53c6579bbdfd700c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies has underperformed the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1787581657,
                "headline": "Are Wall Street Analysts Bullish on Cooper Companies Stock?"
              },
              {
                "id": 141365558,
                "url": "https://finnhub.io/api/news?id=aadfdde577c30bc7effe7096f2d78b4eb7a56e79c4198dfbdc5ab8560dac9910",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.",
                "category": "company",
                "datetime": 1787580816,
                "headline": "1 Healthcare Stock to Target This Week and 2 Facing Headwinds"
              },
              {
                "id": 141283982,
                "url": "https://finnhub.io/api/news?id=c4b2da463c6f09a31ce8e17d294cbf1644931a45b43de4a4e12c8f1e77ee8f38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.",
                "category": "company",
                "datetime": 1787330760,
                "headline": "Here's Why You Should Retain Inogen Stock in Your Portfolio for Now"
              },
              {
                "id": 141278125,
                "url": "https://finnhub.io/api/news?id=c4219d4c8cc06018c3099f6575c54f4f5c3fca8777f4943262f105bf447c2dec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "JNJ's MONARCH QUEST 3 wins FDA 510(k) clearance, adding AI-powered planning, navigation and imaging upgrades for robotic bronchoscopy.",
                "category": "company",
                "datetime": 1787330580,
                "headline": "Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update"
              },
              {
                "id": 141285387,
                "url": "https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "COO vs. MMSI: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1787330403,
                "headline": "COO vs. MMSI: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141283984,
                "url": "https://finnhub.io/api/news?id=b75563b5894b58e0887a3679e9fdda1971893a4221c73767729b846b337b105a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.",
                "category": "company",
                "datetime": 1787330040,
                "headline": "INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?"
              },
              {
                "id": 141283985,
                "url": "https://finnhub.io/api/news?id=b73e213a06b8ca1cf8c2e1fb47c041c4ea799d097e88e7a558e805c84d3ec268",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.",
                "category": "company",
                "datetime": 1787329800,
                "headline": "BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?"
              },
              {
                "id": 141279656,
                "url": "https://finnhub.io/api/news?id=5f941718a2b3dcd6c642c392d28f14263bd1e17229ca84c001ef41096bad7251",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.",
                "category": "company",
                "datetime": 1787328720,
                "headline": "Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"
              },
              {
                "id": 141285388,
                "url": "https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...",
                "category": "company",
                "datetime": 1787285899,
                "headline": "Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"
              },
              {
                "id": 141285389,
                "url": "https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...",
                "category": "company",
                "datetime": 1787275122,
                "headline": "Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"
              },
              {
                "id": 141285398,
                "url": "https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...",
                "category": "company",
                "datetime": 1787256559,
                "headline": "Cooper Companies (COO) Stock Trades At A Premium To Fair Value"
              },
              {
                "id": 141281778,
                "url": "https://finnhub.io/api/news?id=e7adcedb141ab46bd93163e2536b035f1d90bc75f1cf4cfe9ac78f80f75695ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "BD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for incisional hernia prevention.",
                "category": "company",
                "datetime": 1787246580,
                "headline": "BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study"
              },
              {
                "id": 141266860,
                "url": "https://finnhub.io/api/news?id=db611a64fbf03b230be4b5b782e1bab7a0378c9f276b9bc20f8b0c7c17ff967e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.",
                "category": "company",
                "datetime": 1787246040,
                "headline": "MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor"
              },
              {
                "id": 141283992,
                "url": "https://finnhub.io/api/news?id=37eb4fb3fb259704bc8889e42d9c66402dc8110e9f56566c62af937ffc38bd2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.",
                "category": "company",
                "datetime": 1787162100,
                "headline": "HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?"
              },
              {
                "id": 141279330,
                "url": "https://finnhub.io/api/news?id=30e482ac66f335fd06f9335323ecea233f86b3fec37689483b7273b323f2c7d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "ISRG is expanding in Asia Pacific with a new Penang plant to boost capacity and support rising demand for robotic-assisted surgery.",
                "category": "company",
                "datetime": 1787161080,
                "headline": "Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific"
              },
              {
                "id": 141285390,
                "url": "https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1787156762,
                "headline": "CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"
              },
              {
                "id": 141283994,
                "url": "https://finnhub.io/api/news?id=7118fcfc455dcfff25cf8dd09c68938daf08dd78c9ed045f17f2c2487c7c2d8d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Glaukos' iDose TR and Epioxa are driving rapid growth, while margin expansion and a broad pipeline strengthen its long-term prospects.",
                "category": "company",
                "datetime": 1787152500,
                "headline": "Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now"
              },
              {
                "id": 141285391,
                "url": "https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.",
                "category": "company",
                "datetime": 1787074740,
                "headline": "COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"
              },
              {
                "id": 141249262,
                "url": "https://finnhub.io/api/news?id=cd84f8231493ebb18fccd9f4632072f388ae813ad5bb247d4545f99f0bf939a5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/18/Everpure-logo-site.png?width=2048&height=1536",
                "source": "Benzinga",
                "related": "COO",
                "summary": "Jana Partners adds Everpure stock, a growing player in AI and data center market, to its portfolio. It also lowers its stake in other companies.",
                "category": "company",
                "datetime": 1787059139,
                "headline": "Jana Partners Buys Stake in Data Center Stock Everpure, May Be Up Almost 100% Already"
              },
              {
                "id": 141250275,
                "url": "https://finnhub.io/api/news?id=72aa3033993c9773bbace7800f1af4af161f6496b542780f6d21fdea95613697",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "NTRA is using its Latitude MRD test in Kupando's Phase 1 skin cancer trial to track ctDNA and characterize response to KUP-101.",
                "category": "company",
                "datetime": 1786985040,
                "headline": "Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer"
              },
              {
                "id": 141282326,
                "url": "https://finnhub.io/api/news?id=faba776873e4e4ba41ecf84efb154c62932d2516ceb5780783fee8a9aea8c157",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1786891260,
                "headline": "3 S&P 500 Stocks We Think Twice About"
              },
              {
                "id": 141212274,
                "url": "https://finnhub.io/api/news?id=b010713295d26ccd8ae361023b5941c321a3e7758d3f55adeb75362852ecfef6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "HeartFlow (HTFL) delivered earnings and revenue surprises of +50.00% and +12.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786656902,
                "headline": "HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates"
              },
              {
                "id": 141212060,
                "url": "https://finnhub.io/api/news?id=025d57b24590603cb45cf65794b22e0e767d236458c1dda40e82ea69a03ca747",
                "image": "",
                "source": "Benzinga",
                "related": "COO",
                "summary": "Citigroup  analyst Joanne Wuensch   maintains Cooper Companies (NASDAQ:COO) with a Neutral and raises the price target from $76 to $80.",
                "category": "company",
                "datetime": 1786639245,
                "headline": "Citigroup Maintains Neutral on Cooper Companies, Raises Price Target to $80"
              },
              {
                "id": 141205666,
                "url": "https://finnhub.io/api/news?id=6ffa1b74e3016ee2e16dcae1b326a2ce32afa731ce1bdc8b5deda915bb26d23a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cooper Companies' premium lens migration, MiSight growth and fertility recovery offer long-term upside despite Asia-Pacific, tariff and FX pressures.",
                "category": "company",
                "datetime": 1786625460,
                "headline": "Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now"
              },
              {
                "id": 141202656,
                "url": "https://finnhub.io/api/news?id=1465d58e14aa3519a86a6ba0218b0d69cd6cbb5ace1244b8ffb95a68f77f700c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Staar Surgical (STAA) delivered earnings and revenue surprises of +47.62% and +3.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786569002,
                "headline": "Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 141202469,
                "url": "https://finnhub.io/api/news?id=e0277f3fb832d7629b5cfa40809a7c12d4b0dd92ab901d8e20bba9889d3940ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.",
                "category": "company",
                "datetime": 1786548120,
                "headline": "NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up"
              },
              {
                "id": 141202034,
                "url": "https://finnhub.io/api/news?id=c70632c2f9259acf971a4ff2e21f3a79f70231e7041cbbc36844dbb90356e0cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.",
                "category": "company",
                "datetime": 1786465260,
                "headline": "CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up"
              },
              {
                "id": 141202043,
                "url": "https://finnhub.io/api/news?id=211c1e69d0f065f870c9c010a432db201c6207fc440f7474867a1efe9b423f3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "Cardinal (CAH) delivered earnings and revenue surprises of +20.25% and -2.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786449302,
                "headline": "Cardinal Health (CAH) Q4 Earnings Beat Estimates"
              },
              {
                "id": 141177784,
                "url": "https://finnhub.io/api/news?id=2b214d626c55d69f3321fcb009f6866c20e2d848f4d640c809751929b9c57eb4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COO",
                "summary": "INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.",
                "category": "company",
                "datetime": 1786380840,
                "headline": "Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 1,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 44,
            "discarded_article_count": 36
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 13.3,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日4日);Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1745630,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1581910,
              "avg_vol_20": 1647450,
              "avg_vol_30": 1745630,
              "range_pct_10": 0.11079920224553118,
              "range_pct_20": 0.13340224553109775,
              "range_pct_30": 0.13340224553109775,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9062115110304017,
              "dist_to_20d_high": 0.1334016131097171,
              "down_shrink_days": 4,
              "breakout_level_20d": 78.11,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8305647465259682
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.2750775594622548,
              "turnoverUsdM": 197.98553334000002,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.COO",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 64.61,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.6,
            "take_profit_price": 71.2987,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 5.3
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.5501551189245095,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 1.54,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.28
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -126.22
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.322
    },
    "kdj": {
      "d": 10.96,
      "j": 1.61,
      "k": 7.84,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 22.3
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 2206514,
      "recentSlope": -679018.6,
      "previousSlope": -598750
    },
    "rsi": 19.59,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 73.2884,
      "position": "SAR喺價上",
      "distancePct": 8.27,
      "previousTrend": "下降"
    },
    "ma50": 72.5786,
    "macd": {
      "macd": -1.160197162553871,
      "trend": "看跌",
      "signal": -0.40086233124439863,
      "histogram": -0.7593348313094723
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 73.2087,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.75,
      "score": 6,
      "avgVolume": 1674394,
      "currentVolume": 2924886
    },
    "derived": {
      "ma20": 73.348,
      "ma50": 72.5786,
      "prevClose": 69.59,
      "avgVolume10": 1760329,
      "avgVolume20": 1674394,
      "changePercent": -2.73,
      "avgVolumeForScore": 1674394
    },
    "ma_cross": {
      "ma20": 73.348,
      "ma50": 72.5786,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 73.7795,
      "prevMa50": 72.6452,
      "spreadPct": 1.06,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 67.196,
      "upper": 79.5,
      "position": "中間"
    },
    "rsi_short": 21.94,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.75
    }
  }
}

Raw metrics JSON

{
  "close": 67.69,
  "volume": 2924886,
  "changePercent": -2.73
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.